The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer

European Journal of Cancer

Volumn 48, Issue 18, 2012, Pages 3355-3377

  Cardoso, Fatima ^a,b   Loibl, Sibylle ^c   Pagani, Olivia ^d   Graziottin, Alessandra ^e   Panizza, Pietro ^f   Martincich, Laura ^g   Gentilini, Oreste ^h   Peccatori, Fedro ^h   Fourquet, Alain ⁱ   Delaloge, Suzette ^j   Marotti, Lorenza ^k   Penault Llorca, Frédérique ^l   Kotti Kitromilidou, Anna Maria ^c   Rodger, Alan ^m   Harbeck, Nadia ⁿ  

^a Champalimaud Cancer Center   (Portugal)

^b EUROPEAN SCHOOL OF ONCOLOGY   (Italy)

^c German Breast Group ^*  (Cyprus)

^d Breast Unit of Southern Switzerland   (Switzerland)

^e Center of Gynecology and Medical Sexology   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g Fondazione Piemontese per l'Oncologia   (Italy)

^h EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

ⁱ INSTITUT CURIE   (France)

^j INSTITUT GUSTAVE ROUSSY   (France)

^k EUSOMA   (Italy)

^l CENTRE JEAN PERRIN   (France)

^m Radiation Oncology   (United Kingdom)

ⁿ UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Breast cancer; Fertility; Guidelines; Pregnancy; Treatment; Young women

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GONADORELIN DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; TAMOXIFEN; TRASTUZUMAB; ZOLEDRONIC ACID;

ARTICLE; AXILLARY LYMPH NODE; BONE DENSITY; BREAST AUGMENTATION; BREAST CALCIFICATION; BREAST CANCER; BREAST FEEDING; BREAST RECONSTRUCTION; BREAST SELF EXAMINATION; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLINICAL PRACTICE; CONSENSUS; CRYOPRESERVATION; DIGITAL MAMMOGRAPHY; DISEASE FREE SURVIVAL; EARLY MENOPAUSE; ECHOMAMMOGRAPHY; EVIDENCE BASED PRACTICE CENTER; FEBRILE NEUTROPENIA; FEMALE INFERTILITY; FOLLOW UP; FREEZING; HEALTH PRACTITIONER; HORMONAL CONTRACEPTION; HUMAN; INTRADUCTAL CARCINOMA; IONIZING RADIATION; LOCAL RECURRENCE FREE SURVIVAL; LONG TERM SURVIVAL; LOW CALORY DIET; LYMPHEDEMA; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; OVULATION INDUCTION; PALLIATIVE THERAPY; PARTIAL MASTECTOMY; PATIENT CARE; PATIENT COUNSELING; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PREDICTIVE VALUE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SEXUAL DYSFUNCTION; SEXUALITY; SMOKING; SYSTEMIC THERAPY; TERMINAL CARE; TREATMENT DURATION; TRIPLE NEGATIVE BREAST CANCER; WEIGHT REDUCTION;

ADULT; AGE OF ONSET; BREAST IMPLANTS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; DISEASE MANAGEMENT; FEMALE; FERTILITY PRESERVATION; HUMANS; LACTATION; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY; MENOPAUSE, PREMATURE; NEOPLASM STAGING; NEOPLASTIC SYNDROMES, HEREDITARY; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 84869503259     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.10.004     Document Type: Article

References (178)

1. J.M. Greif Mammographic screening for breast cancer: An invited review of the benefits and costs Breast 19 4 2010 268 272
2. S. Samphao, A.J. Wheeler, and E. Rafferty Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging Am J Surg 198 4 2009 538 543
3. H.O. Adami, B. Malker, L. Holmberg, I. Persson, and B. Stone The relation between survival and age at diagnosis in breast cancer N Engl J Med 315 9 1986 559 563 (Pubitemid 16052469)
4. N. Kroman, M.B. Jensen, J. Wohlfahrt, H.T. Mouridsen, P.K. Andersen, and M. Melbye Factors influencing the effect of age on prognosis in breast cancer: population based study BMJ 320 7233 2000 474 478 (Pubitemid 30173116)
5. S.H. Ahn, B.H. Son, and S.W. Kim Korean Breast Cancer Society poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea - a report from the Korean Breast Cancer Society J Clin Oncol 25 17 2007 2360 2368 [Epub 2007 May 21]
6. P.A. Francis Optimal adjuvant therapy for very young breast cancer patients Breast 20 4 2011 297 302 [Epub 2011 May 24]
7. C.K. Anders, D.S. Hsu, and G. Broadwater Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 20 2008 3324 3330
8. C.K. Anders, C. Fan, and J.S. Parker Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 29 1 2011 e18 e20 [Epub 2010 Nov 29. No abstract available]
9. A. de la Rochefordiere, B. Asselain, and F. Campana Age as prognostic factor in premenopausal breast carcinoma Lancet 341 8852 1993 1039 1043 (Pubitemid 23114394)
10. C. Cluze, P. Delafosse, A. Seigneurin, and M. Colonna Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: A population-based study Eur J Cancer Prev 18 5 2009 343 348
11. K. Metcalfe, S. Gershman, and H.T. Lynch Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers Br J Cancer 104 9 2011 1384 1392 [Epub 2011 Apr 12]
12. P. Christiansen, N. Al-Suliman, and K. Bjerre Danish Breast Cancer Cooperative Group. Recurrence pattern and prognosis in low-risk breast cancer patients - data from the DBCG 89-A programme Acta Oncol 47 4 2008 691 703 [Br J Surg. 2009;96(1):40-6] (Pubitemid 351878462)
13. F. Sardanelli, C. Boetes, and B. Borisch Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group Eur J Cancer 46 8 2010 1296 1316 [Epub 2010 Mar 19]
14. A.K. Hackshaw, and E.A. Paul Breast self-examination and death from breast cancer: A metaanalysis Br J Cancer 88 2003 1047 1053 (Pubitemid 36560774)
15. D.B. Thomas, D.L. Gao, and R.M. Ray Randomized trial of breast self-examination in Shanghai: final results J Natl Cancer Inst 94 19 2002 1445 1457 (Pubitemid 35243743)
16. Breast Screening Programme. England 2007-2008. Published January 28, 2009. Office of National Statistics, London.
17. S. Vinnicombe, S.M. Pinto Pereira, V.A. McCormack, S. Shiel, N. Perry, and I.M. Dos Santos Silva Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data Radiology 251 2 2009 347 358 [Review]
18. N.M. Perry, N. Patani, and S.E. Milner The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit Eur Radiol 21 4 2011 676 682
19. L. Tabár, C.J. Fagerberg, and A. Gad Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare Lancet 1 8433 1985 829 832
20. L. Nyström, I. Andersson, N. Bjurstam, J. Frisell, B. Nordenskjöld, and L.E. Rutqvist Long-term effects of mammography screening: updated overview of the Swedish randomised trials Lancet 359 9310 2002 909 919 [Review. Erratum in: Lancet 2002;360(9334):72] (Pubitemid 34246378)
21. P.C. Gotzsche Relation between breast cancer mortality and screening effectiveness: systematic review of the mammography trials Dan Med Bull 58 3 2011 A4246 [Review]
22. Bonnie C. Yankaskas, Sebastien Haneuse, Julie M. Kapp, Karla Kerlikowske, Berta Geller, and Diana S.M. Buist Performance of first mammography examination in women younger than 40 years. For the breast cancer surveillance consortium J Natl Cancer Inst 102 2010 692 701
23. G.D. Dodd American Cancer Society guidelines on screening for breast cancer: An overview Cancer 69 7 Suppl. 1992 1885 1887 [No abstract available]
24. D. Deapen Breast implants and breast cancer: A review of incidence, detection, mortality, and survival Plast Reconstr Surg 120 7 Suppl. 1 2007 70S 80S [Review] (Pubitemid 350306660)
25. M.J. Silverstein, N. Handel, P. Gamagami, E. Waisman, and E.D. Gierson Mammographic measurements before and after augmentation mammaplasty Plast Reconstr Surg 86 6 1990 1126 1130
26. D.L. Miglioretti, C.M. Rutter, and B.M. Geller Effect of breast augmentation on the accuracy of mammography and cancer characteristics JAMA 291 4 2004 442 450 (Pubitemid 38129748)
27. S.A. McIntosh, and K. Horgan Augmentation mammoplasty: effect on diagnosis of breast cancer J Plast Reconstr Aesthet Surg 61 2 2008 124 129 [Epub 2007 Nov 26, Review]
28. N. Handel The effect of silicone implants on the diagnosis, prognosis, and treatment of breast cancer Plast Reconstr Surg 120 7 Suppl. 1 2007 81S 93S [Review] (Pubitemid 350306661)
29. L.M. Foxcroft, E.B. Evans, and A.J. Porter The diagnosis of breast cancer in women younger than 40 Breast 13 4 2004 297 306 (Pubitemid 39172730)
30. N. Houssami, S. Ciatto, L. Irwig, J.M. Simpson, and P. Macaskill The comparative sensitivity of mammography and ultrasound in women with breast symptoms: An age-specific analysis Breast 11 2 2002 125 130 (Pubitemid 34679262)
31. N. Houssami, S. Ciatto, and P. Macaskill Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer J Clin Oncol 26 2008 3248 3258
32. R.M. Mann, C.E. Loo, and T. Wobbes The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast Breast Cancer Res Treat 119 2 2010 415 422
33. M.E. Brennan, N. Houssami, and S. Lord Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management J Clin Oncol 27 33 2009 5640 5649
34. C. Kuhl, S. Weigel, and S. Schrading Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial J Clin Oncol 28 9 2010 1450 1457 [Epub 2010 Feb 22]
35. L. Turnbull, S. Brown, and I. Harvey Comparative effectiveness of MRI in breast cancer (COMICE) trial: A randomised controlled trial Lancet 375 9714 2010 563 571
36. N.H. Peters, S. van Esser, and M.A. van den Bosch Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial Eur J Cancer 47 6 2011 879 886 [Epub 2010 Dec 30]
37. U. Fischer, O. Zachariae, F. Baum, D. Von Heyden, M. Funke, and T. Liersch The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer Eur Radiol 14 2004 1725 1731 (Pubitemid 39386618)
38. L.J. Solin, S.G. Orel, W.T. Hwang, E.E. Harris, and M.D. Schnall Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ J Clin Oncol 26 2008 386 391 (Pubitemid 351171689)
39. N. Hwang, D.E. Schiller, P. Crystal, E. Maki, and D.R. McCready Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy Ann Surg Oncol 16 2009 3000 3009
40. M. Morrow, J. Waters, and E. Morris MRI for breast cancer screening, diagnosis, and treatment Lancet 378 2011 1804 1811
41. N. Houssami, and D.F. Hayes Review of pre-operative magnetic resonance imaging (MRI) in breast cancer: Should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin 59 5 2009 290 302
42. C. Correa, P. McGale, and C. Taylor Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast J Natl Cancer Inst Monogr 10 41 2010 162 177
43. A. Omlin, M. Amichetti, and D. Azria Boost radiotherapy in young women with ductal carcinoma in situ: A multicentre, retrospective study of the Rare Cancer Network Lancet Oncol 7 8 2006 652 656 (Pubitemid 44143777)
44. H. Bartelink, J.C. Horiot, and P. Poortmans Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation N Engl J Med 345 19 2001 1378 1387
45. U. Veronesi, E. Marubini, and L. Mariani Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial Ann Oncol 12 7 2001 997 1003 (Pubitemid 32725776)
46. U. Veronesi, N. Cascinelli, and L. Mariani Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 16 2002 1227 1232 (Pubitemid 35176241)
47. B. Fisher, S. Anderson, and J. Bryant Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 16 2002 1233 1241 (Pubitemid 35176242)
48. A.P. Chung, and V. Sacchini Nipple-sparing mastectomy: where are we now? Surg Oncol 17 4 2008 261 266 [Epub 2008 May 5. Review. Erratum in: Surg Oncol 2010;19(2):114]
49. K. Rhiem, C. Engel, and M. Graeser Contralateral breast cancer risk in patients with familial breast cancer who tested negative for BRCA1 and BRCA2 J Clin Oncol 29 2011 [Suppl; abstr 1013]
50. L.J. Pierce, A.M. Levin, and T.R. Rebbeck Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol 24 16 2006 2437 2443 [Epub 2006 Apr 24] (Pubitemid 46630619)
51. C.A. Garcia-Etienne, M. Barile, and O.D. Gentilini Breast-conserving surgery in BRCA1/2 mutation carriers: Are we approaching an answer? Ann Surg Oncol 16 12 2009 3380 3387
52. L.J. Pierce, M. Strawderman, and S.A. Narod Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol 18 19 2000 3360 3369
53. D.N. Krag, S.J. Anderson, and T.B. Julian National Surgical Adjuvant Breast and Bowel Project. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 10 2007 881 888 (Pubitemid 47488052)
54. O. Gentilini, M. Cremonesi, and G. Trifirò Safety of sentinel node biopsy in pregnant patients with breast cancer Ann Oncol 15 9 2004 1348 1351 (Pubitemid 39295022)
55. O. Gentilini, M. Cremonesi, and A. Toesca Sentinel lymph node biopsy in pregnant patients with breast cancer Eur J Nucl Med Mol Imaging 37 1 2010 78 83 [Epub]
56. N. Wasif, M.A. Maggard, C.Y. Ko, and A.E. Giuliano Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer Arch Surg 145 2 2010 161 166
57. A.E. Giuliano, K.K. Hunt, and K.V. Ballman Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial JAMA 305 6 2011 569 575
58. I.H. Kunkler, P. Canney, and G. van Tienhoven Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial Clin Oncol (R Coll Radiol) 20 1 2008 31 34
59. Early Breast Cancer Trialists' Collaborative Group Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials Lancet 355 9217 2000 1757 1770
60. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 9503 2005 2087 2106 [Review] (Pubitemid 41797643)
61. S.M. Bentzen, R.K. Agrawal, and E.G. Aird The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial Lancet 371 2008 1095 1107
62. H. Bartelink, J.C. Horiot, and P.M. Poortmans Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 22 2007 3259 3265 [Epub 2007 Jun 18] (Pubitemid 47325610)
63. J.S. Vaidya, D.J. Joseph, and J.S. Tobias Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): An international, prospective, randomised, non-inferiority phase 3 trial Lancet 376 9735 2010 91 102 [Erratum in: Lancet 2010;376(9735):90]
64. B.M. Beadle, W.A. Woodward, and T.A. Buchholz The impact of age on outcome in early-stage breast cancer Semin Radiat Oncol 21 1 2011 26 34 [Review]
65. J.W. Gorechlad, E.B. McCabe, and J.H. Higgins Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI? Ann Surg Oncol 15 6 2008 1703 1709 [Epub 2008 Feb 12]
66. M. Kontos, D.S. Allen, O.F. Agbaje, H. Hamed, and I.S. Fentiman Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen Eur J Surg Oncol 37 12 2011 1051 1058
67. N. Houssami Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer Eur J Surg Oncol JAMA 305 8 2011 790 799 [Epub ahead of print]
68. H.J. Kim, J.Y. Kwak, and J.W. Choi Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer Ann Surg Oncol 17 10 2010 2670 2676
69. H.J. Moon, M.J. Kim, and E.K. Kim US surveillance of regional lymph node recurrence after breast cancer surgery Radiology 252 3 2009 673 681
70. K.S. Albain, D.C. Allred, and G.M. Clark Breast cancer outcome and predictors of outcome: Are there age differentials? J Natl Cancer Inst Monogr 16 1994 35 42
71. G. Cancello, P. Maisonneuve, and N. Rotmensz Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women ( <35 years) with operable breast cancer Ann Oncol 21 10 2010 1974 1981 [Epub 2010 Mar 23]
72. S. Paik, S. Shak, and G. Tang multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 27 2004 Dec 30 2817 2826 [Epub 2004 Dec 10] (Pubitemid 40051905)
73. S. Shak, F.L. Baehner, and M. Stein Quantitative Gene Expression analysis in a large cohort of estrogen-receptor positive breast cancers: characterization of the tumor profiles in younger patients (≤40 yrs) and in older patients (≥70 yrs) Cancer Res 70 24 2010 (Suppl. 2)
74. M. Buyse, S. Loi, and L. van'tVeer Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer J Natl Cancer Inst 98 17 2006 1183 1192 (Pubitemid 44390989)
75. S. Loi, B. Haibe-Kains, and C. Desmedt Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade J Clin Oncol 25 10 2007 1239 1246 [Erratum in: J Clin Oncol 2007;25(24):3790] (Pubitemid 46640570)
76. M. Clarke, A.S. Coates, and S.C. Darby Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials Lancet 371 9606 2008 29 40
77. S.M. Swain, J.H. Jeong, and C.E. Geyer Jr. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer N Engl J Med 362 22 2010 2053 2065
78. J. Huober, G. Von Minckwitz, and C. Denkert Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study Breast Cancer Res Treat 124 1 2010 133 140
79. L.M. Brown, B.E. Chen, and R.M. Pfeiffer Risk of second non-hematological malignancies among 376,825 breast cancer survivors Breast Cancer Res Treat 106 3 2007 439 451 (Pubitemid 350029686)
80. J.M. Letourneau, M.E. Melisko, M.I. Cedars, and M.P. Rosen A changing perspective: improving access to fertility preservation Nat Rev Clin Oncol 8 1 2011 56 60
81. D. Mauri, N. Pavlidis, and J.P. Ioannidis Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis J Natl Cancer Inst 97 3 2005 188 194 (Pubitemid 40277368)
82. B. Fisher, J. Bryant, and N. Wolmark Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 8 1998 2672 2685 (Pubitemid 28363030)
83. B. Fisher, J. Dignam, and N. Wolmark Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 9169 1999 1993 2000 (Pubitemid 29271743)
84. P.C. Dubsky, M.F. Gnant, and S. Taucher Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer Clin Breast Cancer 3 1 2002 65 72 (Pubitemid 34546074)
85. L. Bonilla, I. Ben-Aharon, L. Vidal, A. Gafter-Gvili, L. Leibovici, and S.M. Stemmer Dose-dense chemotherapy in nonmetastatic breast cancer: A systematic review and meta-analysis of randomized controlled trials J Natl Cancer Inst 102 24 2010 1845 1854
86. Available from: www.ago-online.org.
87. M.L. Citron, D.A. Berry, and C. Cirrincione Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 J Clin Oncol 21 8 2003 1431 1439 (Pubitemid 46594092)
88. P. Francis, J. Crown, and A. Di Leo Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial J Natl Cancer Inst 100 2 2008 121 133 [Erratum in: J Natl Cancer Inst 2008;100(22):1655] (Pubitemid 351480565)
89. M.S. Aapro, J. Bohlius, and D.A. Cameron 2010 Update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours Eur J Cancer 47 1 2011 8 32
90. B. Gerber, G. Von Minckwitz, and H. Stehle Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study J Clin Oncol 29 2011 2334 2341
91. L. Del Mastro, L. Boni, and A. Michelotti Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial JAMA 306 3 2011 269 276
92. B. Gerber, G. Von Minckwitz, and H. Stehle Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study J Clin Oncol 29 17 2011 2334 2341
93. M. Untch, R.D. Gelber, and C. Jackisch Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial Ann Oncol 19 6 2008 1090 1096 [Epub 2008 Feb 21] (Pubitemid 351796334)
94. M. Gnant, B. Mlineritsch, and H. Stoeger Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial Lancet Oncol 12 7 2011 631 641
95. R. Giuliani, V. Durbecq, and A. Di Leo Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC) Eur J Cancer 43 4 2007 725 735 (Pubitemid 46509445)
96. F. Cardoso, P.L. Bedard, and E.P. Winer On behalf of the ESO-MBC task force. International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy J Natl Cancer Inst 101 2009 1174 1181
97. O. Pagani, E. Senkus, and W. Wood International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC task force: can metastatic breast cancer be cured? J Natl Cancer Inst 102 2010 1 8
98. F. Cardoso, L. Fallowfield, A. Costa, and M. Castiglione On behalf of the ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol Suppl. 6 2011 vi 25 30
99. Available from: www.nccn.org.
100. Available from: www.canceraustralia.nbocc.org.au.
101. A.S. Coates, C. Hürny, and H.F. Peterson Quality-of-life scores predict outcome in metastatic but not early breast cancer J Clin Oncol 18 2000 3768 3774
102. K.I. Pritchard Combining endocrine agents with chemotherapy: which patients and what sequence? Cancer 112 3 Suppl. 2008 718 722 (Pubitemid 351186394)
103. L.B. Michaud, K.L. Jones, and A.U. Buzdar Combination endocrine therapy in the management of breast cancer Oncologist 6 6 2001 538 546 (Pubitemid 33152098)
104. R.W. Carlson, R. Theriault, and C.M. Schurman Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women J Clin Oncol 28 25 2010 3917 3921
105. I.H. Park, J. Ro, and K.S. Lee Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy J Clin Oncol 28 16 2010 2705 2711
106. D.P. Forward, K.L. Cheung, L. Jackson, and J.F. Robertson Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer Br J Cancer 90 3 2004 590 594 (Pubitemid 38297195)
107. J.F. Robertson, V. Semiglazov, and G. Nemsadze Effects of fulvestrant 250 mg in premenopausal women with oestrogen receptor-positive primary breast cancer Eur J Cancer 43 1 2007 64 70 [Epub 2006 Oct 24] (Pubitemid 46054466)
108. O.E. Young, L. Renshaw, and E.J. Macaskill Effects of fulvestrant 750 mg in premenopausal women with oestrogen-receptor-positive primary breast cancer Eur J Cancer 44 3 2008 391 399 [Epub 2007 Dec 20]
109. Y.L. Tham, K. Sexton, R. Kramer, S. Hilsenbeck, and R. Elledge Primary breast cancer phenotypes associated with propensity for central nervous system metastases Cancer 107 4 2006 696 704 (Pubitemid 44232661)
110. S. Lentzsch, P. Reichardt, F. Weber, V. Budach, and B. Dörken Brain metastases in breast cancer: prognostic factors and management Eur J Cancer 35 4 1999 580 585 (Pubitemid 29192966)
111. L.A. Carey, M.G. Ewend, and R. Metzger Central nervous system metastases in women after multimodality therapy for high risk breast cancer Breast Cancer Res Treat 88 2004 273 280 (Pubitemid 40137306)
112. A.J. Evans, J.J. James, and E.J. Cornford Brain metastases from breast cancer: identification of a high-risk group Clin Oncol (R Coll Radiol) 16 2004 345 349 (Pubitemid 38967255)
113. P.H. Levine, and C. Veneroso The epidemiology of inflammatory breast cancer Semin Oncol 35 1 2008 11 16 [Review] (Pubitemid 351282398)
114. F.M. Robertson, M. Bondy, and W. Yang Inflammatory breast cancer: the disease, the biology, the treatment CA Cancer J Clin 60 6 2010 351 375 [Epub 2010 Oct 19]
115. L. Baider, E. Andritsch, and B. Uziely Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings Crit Rev Oncol Hematol 46 1 2003 5 16 (Pubitemid 36369412)
116. K.H. Dow, and P. Lafferty Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy Oncol Nurs Forum 27 10 2000 1555 1564
117. E. Adams, L. McCann, and J. Armes The experiences, needs and concerns of younger women with breast cancer: A meta-ethnography Psychooncology 20 8 2011 851 861
118. P.A. Ganz, and E.E. Hahn Implementing a survivorship care plan for patients with breast cancer J Clin Oncol 26 5 2008 759 767 (Pubitemid 351264389)
119. F. Xue, W.C. Willett, B.A. Rosner, S.E. Hankinson, and K.B. Michels Cigarette smoking and the incidence of breast cancer Arch Intern Med 171 2 2011 125 133
120. C.J. Semple, and T. McCance Parents' experience of cancer who have young children: A literature review Cancer Nurs 33 2 2010 110 118
121. G. Forrest, C. Plumb, S. Ziebland, and A. Stein Breast cancer in young families: A qualitative interview study of fathers and their role and communication with their children following the diagnosis of maternal breast cancer Psychooncology 18 1 2009 96 103
122. G. Forrest, C. Plumb, S. Ziebland, and A. Stein Breast cancer in the family-children's perceptions of their mother's cancer and its initial treatment: qualitative study BMJ 332 7548 2006 998 1003
123. A. Partridge, S. Gelber, R.D. Gelber, M. Castiglione-Gertsch, A. Goldhirsch, and E. Winer Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI Eur J Cancer 43 11 2007 1646 1653 (Pubitemid 47042368)
124. M. Hickey, M. Peate, C.M. Saunders, and M. Friedlander Breast cancer in young women and its impact on reproductive function Hum Reprod Update 15 3 2009 323 339
125. A.H. Partridge, and E.P. Winer Long-term complications of adjuvant chemotherapy for early stage breast cancer Breast Dis 21 2004 55 64
126. B. Thewes, B. Meiser, and V.M. Duric What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol 6 2005 581 588 (Pubitemid 41051936)
127. M. Peate, B. Meiser, M. Hickey, and M. Friedlander The fertility-related concerns, needs and preferences of younger women with breast cancer: A systematic review Breast Cancer Res Treat 116 2 2009 215 223
128. A.M. Jukkala, A. Azuero, P. McNees, G.W. Bates, and K. Meneses Self-assessed knowledge of treatment and fertility preservation in young women with breast cancer Fertil Steril 94 6 2010 Nov 2396 2398
129. A. Graziottin Sexuality, ageing and chronic diseases: iatrogenic premature menopause in cancer survivors H.P.G. Schneider, Menopause: the state of the art 2003 Parthenon Publishing London, UK 408 415
130. A. Graziottin Menopause and sexuality: key issues in premature menopause and beyond G. Creatsas, G. Mastorakos, Women's health and disease vol. 1205 2010 Annals of The New York Academy of Sciences 254 261
131. V. Stearns, K.L. Beebe, M. Iyengar, and E. Dube Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial JAMA 428 2003 2827 2834 (Pubitemid 37430118)
132. S. Loibl, K. Schwedler, and G. Von Minckwitz Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients-a double-blind, randomized study Ann Oncol 18 2007 689 693 (Pubitemid 46523272)
133. C.L. Loprinzi, D. Barton, and T. Rummans Newer antidepressants inhibit hot flashes Menopause 13 2006 546 548 (Pubitemid 44079523)
134. H. Joffe, C.N. Soares, and L.F. Petrillo Treatment of depression and menopause-related symptoms with the serotonin-norepenephrine reuptake inhibitor duloxetine J Clin Psychiatry 68 2007 943 950 (Pubitemid 47015497)
135. E.M. Walker, A.I. Rodriguez, and B. Kohn Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: A randomized controlled trial J Clin Oncol 28 4 2010 634 640
136. S. Loibl, A. Lintermans, A.S. Dieudonné, and P. Neven Management of menopausal symptoms in breast cancer patients Maturitas 68 2011 148 154
137. A.H. Partridge, K.J. Ruddy, and S. Gelber Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer Fertil Steril 94 2 2010 638 644
138. M. De Vos, P. Devroey, and B.C. Fauser Primary ovarian insufficiency Lancet 376 9744 2010 911 921
139. A.M. Jiménez-Gordo, E. Espinosa, P. Zamora, J. Feliu, N. Rodríguez-Salas, and M. González-Barón Pregnancy in a breast cancer patient treated with a LHRH analogue at ablative doses Breast 9 2 2000 110 112 (Pubitemid 30261260)
140. B. Blanc, A. Lazard, J.P. Estrade, A. Agostini, and B. Gurriet Contraceptive methods after gynecological and breast cancer Bull Acad Natl Med 194 3 2010 521 527
141. A. Huria, G. Somlo, and T. Ahles Renaming "chemobrain" Cancer Invest 25 6 2007 373 377
142. S. Kohli, S. Fisher, and Y. Tra The effect of Modafinil on cognitive function in Breast cancer survivors Cancer 115 12 2009 2065 2616
143. A.P. Pecking, B. Février, C. Wargon, and G. Pillion Efficacy of
144. A.P. Pecking Evaluation by lymphoscintigraphy of the effect of a micronized flavonoid fraction (Daflon 500 mg) in the treatment of upper limb lymphedema Int Angiol 14 3 Suppl. 1 1995 39 43 (Pubitemid 26047743)
145. S.A. McLaughlin, M.J. Wright, and K.T. Morris Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements J Clin Oncol 26 32 2008 5213 5219 [Epub 2008 Oct 6]
146. A. Graziottin, and E. Castoldi Sexuality and breast cancer: A review J. Studd, The management of the menopause. The millennium review 2000 2000 Parthenon Publishing London, UK 211 220
147. A. Graziottin, and R. Basson Sexual dysfunctions in women with premature menopause Menopause 11 6 2004 766 777
148. L.R. Schover Sexuality and body image in younger women with breast cancer J Natl Cancer Inst Monogr 16 1994 177 182
149. A. Graziottin Breast cancer and its effects on women's self-image and sexual function I. Goldstein, C. Meston, S. Davis, A. Traish, Women's sexual function and dysfunction: study, diagnosis and treatment 2006 Taylor and Francis London UK 276 281
150. P.A. Ganz, A. Coscarelli, C. Fred, B. Kahn, M.L. Polinsky, and L. Petersen Breast cancer survivors: psychosocial concerns and quality of life Breast Cancer Res Treat 38 2 1996 183 199 (Pubitemid 26102146)
151. A. Graziottin Female sexual dysfunction: treatment K. Bo, B. Berghmans, S. Morkved, M. Van Kampen, Evidence-based physical therapy for the pelvic floor - bridging science and clinical practice 2007 Elsevier Oxford, UK 277 287
152. I. Santos, and C. Clissold Urogenital disorders associated with estrogen deficiency: the role of promestriene as topical estrogen therapy Gynecol Endocrinol 26 9 2010 644 651
153. J.E. Dew, B.G. Wren, and J.A. Eden A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer Climacteric 6 2003 45 52 (Pubitemid 36398872)
154. M. Trinkaus, S. Chin, W. Wolfman, C. Simmons, and M. Clemens Should urogenital atrophy in breast cancer survivors be treated with topical estrogens Oncologist 13 2008 222 231 (Pubitemid 351679897)
155. G. Emilee, J.M. Ussher, and J. Perz Sexuality after breast cancer: A review Maturitas 66 4 2010 397 407 [Epub 2010 May 2]
156. A. Manganiello, L.A. Hoga, L.M. Reberte, C.M. Miranda, and C.A. Rocha Sexuality and quality of life of breast cancer patients post mastectomy Eur J Oncol Nurs 15 2 2011 167 172
157. L.L. Northouse Breast cancer in younger women: effects on interpersonal and family relations Monogr Natl Cancer Inst 16 1994 183 190
158. J.H. Rowland, B.E. Meyerowitz, and C.M. Crespi Addressing intimacy and partner communication after breast cancer: A randomized controlled group intervention Breast Cancer Res Treat 118 1 2009 99 111
159. S. Lee, S. Ozkavukcu, E. Heytens, F. Moy, and K. Oktay Value of early referral to fertility preservation in young women with breast cancer J Clin Oncol 28 31 2010 4683 4686
160. S.J. Lee, L.R. Schover, and A.H. Partridge American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 24 18 2006 2917 2931 (Pubitemid 46655598)
161. G. Pentheroudakis, N. Pavlidis, and M. Castiglione Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 Suppl. 4 2009 178 181
162. J. Baynosa, L.M. Westphal, A. Madrigrano, and I. Wapnir Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation J Am Coll Surg 209 5 2009 603 607
163. I. Ben-Aharon, A. Gafter-Gvili, L. Leibovici, and S.M. Stemmer Pharmacological interventions for fertility preservation during chemotherapy: A systematic review and meta-analysis Breast Cancer Res Treat 122 3 2010 803 811
164. K. Oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks Fertility preservation in breast cancer patients: in vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen Human Reprod 18 2003 90 95 (Pubitemid 36138857)
165. K. Oktay, E. Buyuk, and L. Veeeck Embryo development after heterotopic transplantation of cryopreserved ovarian tissue Lancet 363 2004 837 840 (Pubitemid 38368830)
166. J.S. Jeruss, and T.K. Woodruff Preservation of fertility in patients with cancer N Engl J Med 360 9 2009 902 911
167. K.A. Rodriguez-Wallberg, and K. Oktay Fertility preservation in women with breast cancer Clin Obstet Gynecol 53 4 2010 753 762
168. A.J. Redig, R. Brannigan, S.J. Stryker, T.K. Woodruff, and J.S. Jeruss Incorporating fertility preservation into the care of young oncology patients Cancer 117 1 2011 4 10
169. A.A. Azim, M. Costantini-Ferrando, and K. Oktay Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study J Clin Oncol 26 16 2008 2630 2635
170. J. Donnez, and M.M. Dolmans Cryopreservation of ovarian tissue: An overview Minerva Med 100 5 2009 401 413
171. M. Sonmezer, and K. Oktay Orthotopic and heterotopic ovarian tissue transplantation Best Pract Res Clin Obstet Gynaecol 24 1 2010 113 126
172. M.R. Cruz, J.C. Prestes, D.L. Gimenes, and M.F. Fanelli Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: A systematic review Fertil Steril 94 1 2010 138 143
173. R. Fabbri, G. Pasquinelli, and D. Keane Culture of cryopreserved ovarian tissue: state of the art in 2008 Fertil Steril 91 5 2009 1619 1629
174. H.A. Azim Jr., L. Santoro, and N. Pavlidis Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies Eur J Cancer 47 1 2011 74 83
175. O. Pagani, A. Partridge, and L. Korde Pregnancy after breast cancer: if you wish, ma'am Breast Cancer Res Treat 129 2 2011 309 317
176. H.A. Azim Jr., G. Bellettini, S. Gelber, and F.A. Peccatori Breast-feeding after breast cancer: if you wish, madam Breast Cancer Res Treat 114 1 2009 7 12 [Epub 2008 Mar 29. Review]
177. H.A. Azim Jr., G. Bellettini, and S.J. Liptrott Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome Breast 19 6 2010 527 531
178. F. Amant, S. Deckers, and K. Van Calsteren Breast cancer in pregnancy: recommendations of an international consensus meeting Eur J Cancer 46 18 2010 3158 3168